CENTRE ANTOINE LACASSAGNE
🇫🇷France
- Country
- 🇫🇷France
- Ownership
- -
- Established
- 1961-01-01
- Employees
- -
- Market Cap
- -
Sunitinib Malate in Treating Patients With Kidney Cancer
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-07-22
- Last Posted Date
- 2016-11-10
- Lead Sponsor
- Centre Antoine Lacassagne
- Target Recruit Count
- 60
- Registration Number
- NCT00943839
- Locations
- 🇫🇷
Centre Antoine Lacassagne, Nice, France
Trastuzumab in Treating Women With Metastatic Breast Cancer
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-05-11
- Last Posted Date
- 2015-02-10
- Lead Sponsor
- Centre Antoine Lacassagne
- Target Recruit Count
- 49
- Registration Number
- NCT00896376
- Locations
- 🇫🇷
Centre Antoine Lacassagne, Nice, France
Gemcitabine, Capecitabine, and Erlotinib in Treating Patients With Advanced Pancreatic Cancer
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-04-21
- Last Posted Date
- 2015-02-10
- Lead Sponsor
- Centre Antoine Lacassagne
- Target Recruit Count
- 30
- Registration Number
- NCT00885066
- Locations
- 🇫🇷
Centre Antoine Lacassagne, Nice, France
Chemotherapy, Radiation Therapy, and Cetuximab in Treating Patients With the Head and Neck Cancer
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-04-03
- Last Posted Date
- 2014-11-21
- Lead Sponsor
- Centre Antoine Lacassagne
- Target Recruit Count
- 53
- Registration Number
- NCT00875849
- Locations
- 🇫🇷
Centre Antoine Lacassagne, Nice, France
MRI in Assessing Tumor Size in Women With Ductal Carcinoma In Situ
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-04-02
- Last Posted Date
- 2014-11-21
- Lead Sponsor
- Centre Antoine Lacassagne
- Target Recruit Count
- 40
- Registration Number
- NCT00874458
- Locations
- 🇫🇷
Centre Antoine Lacassagne, Nice, France
Radiation Therapy and Docetaxel Followed by Standard Therapy in Treating Women With Breast Cancer
Phase 1
Completed
- Conditions
- Interventions
- Drug: cyclophosphamideDrug: docetaxelDrug: epirubicin hydrochlorideDrug: fluorouracilProcedure: neoadjuvant therapyProcedure: therapeutic conventional surgeryRadiation: hypofractionated radiation therapyRadiation: image-guided radiation therapyRadiation: radiation therapyRadiation: stereotactic radiosurgery
- First Posted Date
- 2009-03-31
- Last Posted Date
- 2015-02-10
- Lead Sponsor
- Centre Antoine Lacassagne
- Target Recruit Count
- 26
- Registration Number
- NCT00872625
- Locations
- 🇫🇷
Centre Antoine Lacassagne, Nice, France
Study of Nutrition Regimens in Treating Patients With Cancer of the Upper Aerodigestive Tract
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-10-03
- Last Posted Date
- 2015-02-10
- Lead Sponsor
- Centre Antoine Lacassagne
- Target Recruit Count
- 311
- Registration Number
- NCT00765440
- Locations
- 🇫🇷
Centre Antoine Lacassagne, Nice, France
Combination Chemotherapy, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Newly Diagnosed Large B-Cell Lymphoma
- First Posted Date
- 2008-06-04
- Last Posted Date
- 2015-02-10
- Lead Sponsor
- Centre Antoine Lacassagne
- Target Recruit Count
- 30
- Registration Number
- NCT00690560
- Locations
- 🇫🇷
Centre Antoine Lacassagne, Nice, France
© Copyright 2024. All Rights Reserved by MedPath